Skip to main content
Veterinary Medicines

Cyclix 250 microgram/ml solution for injection for cattle

Authorised
  • Cloprostenol sodium

Product identification

Medicine name:
Cyclix 250 microgram/ml solution for injection for cattle
Cyclix 250 µg/ml Solution Injectable pour bovins
Active substance:
  • Cloprostenol sodium
Target species:
  • Cattle
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Cloprostenol sodium
    263.00
    microgram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        2
        day
      • Milk
        0
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        2
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG02AD90
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • (ID2) 50 millilitre(s): unspecified outer container with 1 Vial (Glass) with 50 millilitre(s)
  • (ID1) 20 millilitre(s): unspecified outer container with 1 Vial (Glass) with 20 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • VIRBAC
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V/859/06/04/0869
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0111/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
French (PDF)
Published on: 22/06/2022

Combined File of all Documents

English (PDF)
Published on: 22/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."